Clinical applications of electrochemotherapy

Advanced Drug Delivery Reviews

Volumn 35, Issue 1, 1999, Pages 119-129

  Heller, Richard ^a,b   Gilbert, Richard ^b   Jaroszeski, Mark J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b University of South Florida   (United States)

Author keywords

Bleomycin; Chemotherapy; Cisplatin; Clinical trial; Electropermeabilization; Electroporation

Indexed keywords

BIOELECTRIC PHENOMENA; CELL MEMBRANES; CHEMOTHERAPY; ELECTRIC FIELD EFFECTS; MECHANICAL PERMEABILITY;

ELECTROCHEMOTHERAPY; ELECTROPORATION;

CONTROLLED DRUG DELIVERY;

BLEOMYCIN;

ADENOCARCINOMA; ARTICLE; BREAST CARCINOMA; DRUG DELIVERY SYSTEM; ELECTRIC FIELD; ELECTROCHEMOTHERAPY; ELECTROPORATION; HEAD AND NECK CARCINOMA; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; MELANOMA; PRIORITY JOURNAL; SKIN PERMEABILITY; SQUAMOUS CELL CARCINOMA; TECHNIQUE; TUMOR VOLUME;

EID: 0033521544     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00067-2     Document Type: Article

References (60)

1. Coates A.S. Systemic chemotherapy for malignant melanoma. World J. Surg. 16(2):1992;277-281.
2. Nathanson L., Jilani S. Chemotherapy of malignant melanoma. Cancer Treat. Rev. 19(1):1993;17-28.
3. Yeung R.S. Management of recurrent cutaneous melanoma. Curr. Probl. Cancer. 18(3):1994;143-186.
4. Buzaid A.C., Murren J. Chemotherapy for advanced malignant melanoma. Int. J. Clin. Lab. Res. 21(3):1992;205-209.
5. D.C. Chang, B.M. Chassy, J.A. Saunders, A.E. Sowers (Eds.), Guide to electroporation and electrofusion, Academic Press, San Diego, CA, 1992.
6. Potter H. Electroporation in biology: methods, applications and instrumentation. Anal. Biochem. 174:1988;361-373.
7. Weaver J.C. Electroporation: a general phenomenon for manipulating cells and tissues. J. Cell. Biochem. 51:1993;426-435.
8. R. Heller, R. Gilbert, Biological applications of cell-tissue electrofusion, in: D.C. Chang, B.M. Chassy, J.A. Saunders, A.E. Sowers (Eds.), Guide to Electroporation and Electrofusion, Academic Press, San Diego, CA, 1992, pp. 393-410.
9. Foung S.K.H., Perkins S. Electric field-induced cell fusion and human monoclonal antibodies. J. Immunol. Meth. 116:1989;117-122.
10. Lo M.M.S., Tsong T.Y., Conrad M.K., Strittmatter S.M., Hester L.D., Snyder S.H. Monoclonal antibody production by receptor-mediated electrically induced cell fusion. Nature. 310:1984;792-794.
11. Teissie J., Knutson V.P., Tsong T.Y., Lane M.D. Electric pulse-induced fusion of 3T3 cells in monolayer culture. Science. 216:1982;537-538.
12. Jaroszeski M.J., Gilbert R., Fallon P.G., Heller R R. Mechanically facilitated cell-cell electrofusion. Biophys. J. 67:1994;1574-1581.
13. Heller R., Grasso R.J. Transfer of human membrane surface components by incorporating human cells into intact animal tissue by cell-tissue electrofusion in vivo. Biochem. Biophys. Acta. 1024:1990;185-188.
14. Grasso R.J., Heller R., Cooley J.C., Haller E.M. Electrofusion of individual animal cells directly to intact corneal epithelial tissue. Biochem. Biophys. Acta. 980:1989;9-14.
15. Mouneimne Y., Pierre-Francois T., Barhoumi R., Nicolau C. Electroinsertion of xeno proteins in red blood cell membranes yields a long lived protein carrier in circulation. Biochim. Biophys. Acta. 1066:1991;83-89.
16. Mouneimne Y., Pierre-Francois T., Barhoumi R., Nicolau C. Electroinsertion of full length recombinant CD4 into red blood cell membrane. Biochim. Biophys. Acta. 1027:1990;53-58.
17. Chernomordik L.V., Sokolov A.V., Budker V.G. Electrostimulated uptake of DNA by liposomes. Biochem. Biophys. Acta. 1024:1990;179-183.
18. Zheng Q., Chang D.C. High-efficiency gene transfection by in situ electroporation of cultured cells. Biochem. Biophys. Acta. 1088:1991;104-110.
19. Heller R., Jaroszeski M.J., Atkin A., Moradpour D., Gilbert R., Wands J., Nicolau C. In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389:1996;225-228.
20. Prausnitz M.R., Lau B.S., Milano C.D., Conner S., Langer R., Weaver J.C. A quantitative study of electroporation showing a plateau in net molecular transport. Biophys. J. 65:1993;414-422.
21. Hibino M., Shigemori M., Itoh M., Hagayama K., Kinosita K. Membrane conductance of an electroporated cell analyzed by submicrosecond imaging of transmembrane potential. Biophys. J. 59:1991;209-220.
22. Mehrl W., Zimmermann U., Hamp R. Evidence for asymmetrical uptake of fluorescent dyes through electro-permeabilized membranes of avena mesophyll protoplasts. FEBS Lett. 185:1985;89-94.
23. Mir L.M., Orlowski S., Belehradek J. Jr., Paoletti C. Electrochemotherapy: potentiation of antitumor effect of bleomycin by local electric pulses. Eur. J. Cancer. 27:1991;68-72.
24. Belehradek J. Jr., Orlowski S., Poddevin B., Paoletti C., Mir L.M. Electrochemotherapy of spontaneous mammory tumors in mice. Eur. J. Cancer. 27:1991;73-76.
25. Okino M., Tomie H., Kanesada H., Marumoto M., Esato K., Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn. J. Cancer Res. 83:1992;1095-1101.
26. Heller R., Jaroszeski M., Leo-Messina J., Perrott R., Van Voorhis N., Reintgen D.et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem. Bioenerg. 36:1995;83-87.
27. Sersa G., Cemazar M., Miklavcic D., Mir L.M. Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectrochem. Bioenerg. 35:1994;23-27.
28. Heller R., Jaroszeski M., Perrott R., Messina J., Gilbert R. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 7:1997;10-18.
29. Okino M., Marumoto M., Kanesada H., Kuga K., Mohri H. Electrical impulse chemotherapy for rat solid tumors. Proc. Jpn. Cancer Congress. 46:1987;420.
30. Okino M., Esato K. The effects of a single high voltage electrical stimulation with anticancer drug on in vivo growing malignant tumors. Jpn. J. Surg. 20:1990;197-204.
31. Okino M., Tomie H., Kanesada H., Marumoto M., Morita N., Esato K.et al. Induction of tumor specific selective toxicity in electrical impulse chemotherapy - analysis of dose response curve. Oncologia. 24:1991;71-79.
32. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma. J. Jpn. Soc. Cancer Ther. 25:1990;2640-2648.
33. Salford L.G., Persson B.R.R., Brun A., Ceberg C.P., Kongstad P.Ch., Mir L.M. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem. Biophys. Res. Commun. 194(2):1993;938-943.
34. Yamaguchi O., Irisawa C., Baba K., Ogihara M., Yokota T., Shiraiwa Y. Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tohoku J. Exp. Med. 172:1994;291-293.
35. Jaroszeski M.J., Gilbert R., Heller R. Successful treatment of hepatomas with electrochemotherapy in a rat model. Biochem. Biophys. Acta. 1334:1997;15-18.
36. Jaroszeski M.J., Gilbert R., Perrott R., Heller R. Enhanced effects of multiple treatment electrochemotherapy. Melanoma Res. 6:1996;427-433.
37. Sersa G., Cemazar M., Semrov D., Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectrochem. Bioenerg. 39:1996;61-66.
38. Cemazar M., Miklavcic D., Vodovnik L., Jarm T., Zvonimir R., Stabuc B., Cufer T., Sersa G. Improved therapeutic effect of electrochemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice. Radiol. Oncol. 29:1995;121-127.
39. Mir L.M., Devauchelle P., Quintin-Colonna F., Delisle F., Fradelizi D., Belehradek J. Jr., Orlowski S. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br. J. Cancer. 76(12):1997;1617-1622.
40. Mir L.M., Belehradek M., Domenge C., Orlowski S., Poddevin J. Jr., Schwab G.et al. Electrochemotherapy, a novel antitumor treatment: first clinical trial. C.R. Acad. Sci. Paris. 313:1991;613-618.
41. Belehradek M., Domenge C., Luboinnski B., Orlowski S., Belehradek J., Mir L.M. Electrochemotherapy, a new antitumor treatment: first clinical phase I-II trial. Cancer. 72(12):1993;3694-3700.
42. Domenge C., Orlowski S., Luboinski B., De Baere T., Schwaab G., Belehradek J. Jr.et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer. 77(5):1996;956-963.
43. Heller R., Jaroszeski M.J., Glass L.F., Messina J.L., Rapaport D.P., DeConti R.C.et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 77(5):1996;964-971.
44. D.S. Reintgen, M.J. Jaroszeski, R. Heller, Electrochemotherapy, a novel approach to cancer, J. Skin Cancer Foundation, XIV (1996) 17-19,83.
45. Glass L.F., Jaroszeski M.J., Gilbert R., Reintgen D.S., Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J. Am. Acad. Dermatol. 37(4):1997;596-599.
46. Hofmann G.A., Dev S.B., Nanda G.S. Electrochemotherapy: transition from laboratory to the clinic. IEEE Eng. Med. Biol. 15:1996;124-132.
47. Gilbert R., Jaroszeski M.J., Heller R. Novel electrode designs for electrochemotherapy. Biochem. Biophys. Acta. 1334:1997;9-14.
48. Rudolf Z., Stabuc B., Cemazar M., Miklavcic D., Vodovnik L., Sersa G. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol. Oncol. 29:1995;229-235.
49. Glass L.F., Pepine M.L., Fenske N.A., Jaroszeski M.J., Reintgen D.S., Heller R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch. Dermatol. 132:1996;1353-1357.
50. Mir L.M., Glass L.F., Sersa G., Teissie J., Domenge C., Miklavcic D., Jaroszeski M.J., Orlowski S., Reintgen D.et al. Br. J. Cancer. 77(12):1998;2336-2342.
51. C.M. Balch, A.N. Houghton, L.J. Peters, in: V.T. DeVita Jr, S. Hellman, S.A. Rosenberg (Eds.), Cancer Principles and Practice of Oncology, Table 46-7, Lippincott, 1993, p. 1637.
52. Retsas S. Strategies for improving survival in malignant melanoma; focus on vindesine. J. Drug Dev. Clin. Pract. 7:1995;159-171.
53. Pron G., Belehradek J. Jr., Mir L.M. Identification of a plasma membrane protein that specifically binds bleomycin. Biochem. Biophys. Res. Commun. 194:1993;333-337.
54. Poddevin B., Orlowski S., Belehradek J. Jr., Mir L.M. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42(S):1991;67-75.
55. E. Neumann, A.E. Sowers, C.A. Jordan. Electroporation and Electrofusion in Cell Biology, Plenum, New York, 1989.
56. Orlowski S., Mir L.M. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim. Biophys. Acta. 1154:1993;51-63.
57. Tounekti O., Pron G., Belehradek J. Jr., Mir L.M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53:1993;5462-5469.
58. Mir L.M., Orlowski S., Poddevin B., Belehradek J. Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur. Cytokine Netw. 3:1992;331-334.
59. Mir L.M., Roth C., Orlowski S., Belehradek Jr J., Fradelizi F., Paoletti C.et al. Potentiation of the antitumoral effect of electrochemotherapy by an immunotherapy with allogeneic cells producing interleukin-2. C.R. Acad. Sci. Paris. 314:1992;539-544.
60. M Mir L., Roth C., Orlowski S., Quintin-Colonna F., Fradelizi F., Belehradek J. Jr.et al. Systemic antitumor effects of electrochemotherapy combined with histocompatible cells secreting interleukin-2. J. Immunol. 17:1995;30-38.